Abbott Laboratories (ABT) Net Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.69% |
| Dec 31, 2025 | 238.44% |
| Mar 31, 2025 | 131.33% |
| Dec 31, 2024 | 97.28% |
| Sep 30, 2024 | 11.39% |
| Jun 30, 2024 | 5.29% |
| Mar 31, 2024 | 12.76% |
| Dec 31, 2023 | 337.13% |
| Sep 30, 2023 | 164.94% |
| Jun 30, 2023 | 146.86% |
| Mar 31, 2023 | 171.10% |
| Dec 31, 2022 | 95.69% |
| Sep 30, 2022 | 102.64% |
| Jun 30, 2022 | 174.28% |
| Mar 31, 2022 | 136.61% |
| Dec 31, 2021 | 127.00% |
| Sep 30, 2021 | 137.14% |
| Jun 30, 2021 | 136.71% |
| Mar 31, 2021 | 156.98% |
| Dec 31, 2020 | -70.40% |
| Mar 31, 2020 | -31.23% |
| Dec 31, 2019 | -26.40% |
| Sep 30, 2019 | 57.20% |
| Jun 30, 2019 | 89.65% |
| Mar 31, 2019 | 34.80% |
| Dec 31, 2018 | -14.98% |
| Sep 30, 2018 | -49.10% |
| Jun 30, 2018 | -49.92% |
| Mar 31, 2018 | -55.97% |
| Dec 31, 2017 | -54.84% |
| Sep 30, 2017 | -51.74% |
| Jun 30, 2017 | -60.27% |
| Mar 31, 2017 | -48.27% |
| Dec 31, 2016 | 15.14% |
| Sep 30, 2016 | -37.90% |
| Jun 30, 2016 | -61.71% |
| Mar 31, 2016 | -54.97% |
| Dec 31, 2015 | 18.18% |
| Sep 30, 2015 | -55.24% |
| Jun 30, 2015 | -14.88% |
| Mar 31, 2015 | -33.55% |
| Dec 31, 2014 | -34.69% |
| Sep 30, 2014 | -41.67% |
| Jun 30, 2014 | -49.82% |